Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

What does CMS' proposed addition of Heart Stenting in ASCs mean to Hospitals?

Partner News | Published: Monday, August 12, 2019

As the cardiovascular outpatient migration continues with the proposed addition of PCI in the ASC setting, how will it affect Hospitals? What can health systems do to participate in cardiovascular procedures

Biome Wins 2019 Healthcare Startups to Watch Award

Partner News | Published: Thursday, August 8, 2019

Biome Analytics was named 2019 Healthcare Startups to Watch by InsightsCare magazine; designated as ‘Best-in-Class’ solution in annual ‘Healthcare Startups to Watch’ Awards, honoring

MedAxiom Announces Industry Partnership with Biome Analytics

Partner News | Published: Wednesday, August 7, 2019

Biome Analytics delivers a new generation of clinical performance applications, aligning hospitals and doctors around actionable clinical & cost insights in days.


Introducing PICOM ModalityGuard™ by ScImage

Partner News | Published: Tuesday, August 6, 2019

ScImage, Inc. is bridging the gap between security and functionality with the introduction of the PICOM ModalityGuard™. Health institutions no longer need to choose between being prepared for security threats and having a flexible and interoperable PACS workflow.


Cardiovascular Service Line RoundTables

Partner News | Published: Friday, July 26, 2019

To effectively tackle the key challenges in cardiovascular care, a novel framework was created to help drive transformations to improve the clinical, financial and operational outcomes of the CV service lines. This framework – the CV TRIAD – is built on the TRIAD collaboration of Physician Leadership, Administrators, and Industry creating a community of thought leaders committed to Reinventing Cardiovascular care.


pMD Announces Free Secure Patient Communication

Partner News | Published: Wednesday, July 24, 2019

pMD, the innovation leader in health care technology, announced in a press release a free HIPAA-compliant communication platform to better connect  providers with patients.


Early Returns for Groups Participating in Medicare’s BPCI Advanced Program

Partner News | Published: Monday, July 1, 2019

Cardiac Interventions Today article co-authored by MedAxiom’s EVP of Consulting Joel Sauer and Archway Health’s GM of BPCI Advanced Keely Macmillan reviews the BPCI Advanced program and enhancements made.


Prairie Heart Successfully Implements HeartFlow Analysis

Partner News | Published: Wednesday, June 5, 2019

Prairie Heart and HeartFlow, Inc. team up to implement the HeartFlow Analysis with great success. Hear what the Prairie Heart team has to say about their journey and how this program has helped improve the diagnosis and treatment of patients with coronary artery diease, while also improving the overall patient experience.


Geneva Health Solutions Scientific Study Featured at 2019 Heart Rhythm Society (HRS) Conference

Partner News | Published: Monday, June 3, 2019

Overwhelmed by device data? Geneva Health Solutions, one of the leading solutions provider for cardiac device technology, conducted a scientific study that was featured at the 2019 Heart Rhythm Society (HRS) conference. In the study led by co-founder and chief medical officer, Dr Manish Wadhwa, researchers found that implementing the Geneva platform—as a management system for remote monitoring data—effectively reduced data deluge and improved the quality of patient reports, thereby ensuring the most actionable information was routed to those on the front lines of patient care.


Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease

Partner News | Published: Thursday, May 23, 2019

HeartFlow, Inc., announced new data demonstrating that the use of the investigational HeartFlow Planner, a real-time, non-invasive interactive planning tool, led to a change in treatment strategy in 45% of patients with coronary artery disease (CAD) and reduced the need for invasive physiology.